Smith & Nephew SNATS (NYSE:SNN) Upgraded at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of Smith & Nephew SNATS (NYSE:SNN – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday.

A number of other equities analysts also recently commented on the company. Canaccord Genuity Group decreased their target price on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a research note on Tuesday, November 11th. Kepler Capital Markets upgraded Smith & Nephew SNATS to a “strong-buy” rating in a research report on Monday, November 17th. Sanford C. Bernstein set a $37.50 target price on Smith & Nephew SNATS and gave the stock a “market perform” rating in a research report on Tuesday, October 14th. Royal Bank Of Canada cut Smith & Nephew SNATS from an “outperform” rating to a “sector perform” rating in a research note on Monday, December 15th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $35.75.

View Our Latest Stock Report on Smith & Nephew SNATS

Smith & Nephew SNATS Price Performance

NYSE SNN opened at $33.69 on Friday. Smith & Nephew SNATS has a one year low of $23.69 and a one year high of $38.79. The company has a 50-day simple moving average of $33.15 and a 200-day simple moving average of $34.24. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60.

Institutional Trading of Smith & Nephew SNATS

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd bought a new position in shares of Smith & Nephew SNATS in the third quarter valued at approximately $41,000. Northwestern Mutual Wealth Management Co. lifted its position in Smith & Nephew SNATS by 105.8% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 712 shares during the period. Huntington National Bank lifted its position in Smith & Nephew SNATS by 1,837.0% in the third quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 1,341 shares during the period. AlphaCore Capital LLC bought a new position in Smith & Nephew SNATS during the 2nd quarter valued at $44,000. Finally, Smartleaf Asset Management LLC increased its position in shares of Smith & Nephew SNATS by 1,222.3% during the 3rd quarter. Smartleaf Asset Management LLC now owns 2,486 shares of the medical equipment provider’s stock valued at $88,000 after purchasing an additional 2,298 shares during the period. 25.64% of the stock is currently owned by institutional investors.

About Smith & Nephew SNATS

(Get Free Report)

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.

Read More